Belgium
Belgium: Covid-19: use of unlicensed medicines for treatment of Covid-19
03 August 2020 - Posted by: Tine Carmeliet
Recently, Royal Decree no 34 was published, containing measures to ensure the availability and proper management of medicinal products during the Covid-19 pandemic. The royal decree enables the Minister of Health to authorise a product from Belgium’s strategic stockpile of medicinal products that is not licensed for the treatment of Covid-19 to be used for › Read More
Belgium: Covid-19 – Coronavirus: serological tests now available
14 July 2020 - Posted by: Tine Carmeliet
Certain serological tests for Covid-19 have been made available to the public in Belgium. The tests examine for the presence of antibodies against Covid-19 and enable patients to know whether they have been infected in the past. On 13 May 2020, a Royal Decree on temporary measures in the fight against the Covid-19 pandemic and › Read More
Belgium – Covid-19 coronavirus: measures affecting the life sciences sector
10 June 2020 - Posted by: Tine Carmeliet
In the fight against the Covid-19 coronavirus pandemic, the Belgium government has taken several exceptional measures, including (i) restricting the sale of certain medical devices and personal protective equipment; (ii) issuing a Guideline for the reuse of surgical masks and FFP2/FFP3 masks; and (iii) communicating on how Covid-19 tests should be made available in Belgium. › Read More
Belgium: Covid-19 – Coronavirus: updated guidance on managing clinical trials during pandemic
05 June 2020 - Posted by: Veerle Pissierssens
On April 2020, the Belgian government updated its Guidance on the management of clinical trials during the Covid-19 coronavirus pandemic, in line with the development of the Covid-19 pandemic. The guidance was initially issued on 25 March 2020, following EU guidance of the same name (see our previous post here). The Belgian guidance supplements EU › Read More
04 June 2020 - Posted by: Veerle Pissierssens
The Belgian Guidance on the Management of Clinical Investigations during the Covid-19 (Coronavirus) pandemic has been developed to mitigate the negative effects of the Covid-19 pandemic on the conduct of clinical investigations of medical devices. The exceptional circumstances create various challenges (for example, restrictions of visits to healthcare facilities and self-isolation of patients) that have › Read More